Phase II trial of BRACAnalysis in metastatic triple negative breast cancer patients to identify which patients would respond to carboplatin or docetaxel

Trial Profile

Phase II trial of BRACAnalysis in metastatic triple negative breast cancer patients to identify which patients would respond to carboplatin or docetaxel

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Jul 2015

At a glance

  • Drugs Olaparib (Primary) ; Carboplatin; Docetaxel
  • Indications Advanced breast cancer
  • Focus Diagnostic use
  • Most Recent Events

    • 24 Jul 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top